$AGEN 3 SEC Filings

Filed On	Filing
15 Sep 2026	Form 3: Marcucci Marco Tullio, Director Holds 4,480 shares of Common Stock
16 Jan 2026	Form 3: Charette Austin, Principal Accounting Officer Holds 9,115 shares of Common Stock
08 Aug 2024	Form 3: Harrison Thomas L, Director
20 Jun 2024	Form 3: Buell Jennifer, Director Holds 13,670 shares of Common Stock
20 Oct 2021	Form 3: Agenus Inc, 10% owner · Mink Therapeutics Inc Holds 19,481,000 shares of Common Stock
12 Feb 2021	Form 3: O'Day Steven J, Chief Medical Officer
21 Dec 2020	Form 3: Krauss Adam, Chief Legal Officer
13 Oct 2020	Form 3: Hirsch Susan B, Director Holds 55,750 shares of Common Stock
31 Aug 2020	Form 3: Clark Paul N, Director Holds 70,805 shares of Common Stock
14 Nov 2018	Form 3: Jeynes-Ellis Allison M, Director No securities owned
13 Jul 2018	Form 3: Kearns Evan, VP, General Counsel Holds 12,915 shares of Common Stock
22 Jun 2018	Form 3: Cortis Christian, Chief Strategy Officer Holds 19,849 shares of Common Stock
07 Jul 2017	Form 3: Duncan Alex, Chief Technology Officer Holds 14,149 shares of Common Stock
07 Jul 2017	Form 3: Buell Jennifer, VP Research & External Affairs Holds 24,361 shares of Common Stock
30 Jan 2017	Form 3: Cuillerot Jean-Marie, Chief Medical Officer
19 May 2016	Form 3: Wiinberg Ulf, Director No securities owned
17 Jun 2015	Form 3: Ballantyne Charles Evan, Chief Financial Officer No securities owned
20 Feb 2015	Form 3: Incyte Corp, 10% owner Holds 7,763,968 shares of Common Stock
24 Feb 2014	Form 3: Malik Shahzad, Director Holds 996,088 shares of Common Stock
14 Feb 2014	Form 3: Qvt Associates Gp Llc, 10% owner and 1 other Holds 9,259,260 shares of Common Stock, $0.01 par value

Comments